Biomea Fusion Stock (NASDAQ: BMEA) stock price, news, charts, stock research, profile.
You can purchase shares of Biomea Fusion (NASDAQ:BMEA) through any online brokerage.
Other companies in Biomea Fusion’s space includes: Precigen (NASDAQ:PGEN), Zentalis Pharma (NASDAQ:ZNTL), PepGen (NASDAQ:PEPG), TScan Therapeutics (NASDAQ:TCRX) and Genfit (NASDAQ:GNFT).
Biomea Fusion has a consensus price target of $23.21.
The stock price for Biomea Fusion (NASDAQ: BMEA) is $8.15 last updated September 25, 2024 at 11:33 AM EDT.
There are no upcoming dividends for Biomea Fusion.
Biomea Fusion’s Q3 earnings are confirmed for Monday, October 28, 2024.
There is no upcoming split for Biomea Fusion.
Biomea Fusion is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.